WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

ASSOCIATION OF GENETIC POLYMORPHISMS IN GSTT1, GSTM1 GENES IN PATIENTS WITH DIABETIC RETINOPATHY AND NEPHROPATHY IN SOUTH INDIAN POPULATION

M. A. Jaleel Tabrez, *Kaiser Jamil, Sindhu Joshi and Uma Devi M.

ABSTRACT

Oxidative stress has been implicated as a critical factor in pathogenesis of type 2 diabetes mellitus (T2DM) and its complications Diabetic Nephropathy (DN) and Diabetic Retinopathy (DR). Our aim was to evaluate the frequency of null polymorphisms in GSTT1 and GSTM1 genes, members of class II detoxification enzymes, in a South Indian population and their association with DR and DN in T2DM. Blood samples were collected from 63 T2DM patients with DR and/or DN and from 50 healthy controls. After genomic DNA extraction, multiplex PCR assay was performed using specific primers and various clinic-pathological parameters were correlated. Our results suggest that the frequency of null polymorphisms in GSTM1 and GSTT1 were higher in patients (32% and 48% respectively) when compared to controls (16% and 28% respectively). Overall, GSTT1 null polymorphism was significantly associated with diabetes when compared to controls (p=0.039). Interestingly, a large percentage of the female patients were dyslipidemic (64.86%). In conclusion, our study indicates that patients with null polymorphisms in GSTM1 and GSTT1 may have adverse pathophysiological effects which could contribute to DN and DR complications in T2DM.

Keywords: GSTM1, GSTT1, null polymorphism, diabetes retinopathy, diabetes nephropathy, type 2 diabetes mellitus


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More